CA Analytical Testing Services
CA Analytical Testing Services is an FDA inspected contract laboratory and drug development partner providing integrated analytical, microbiological, formulation, and CMC support across the product lifecycle. We can integrate directly into development programs to provide analytical method development, microbiological support, formulation and characterization activities, and problem-solving throughout early- and late-stage development. Beyond laboratory testing, CA Analytical can support broader drug and medical device programs through CDMO selection and qualification, technology transfer, third-party quality and manufacturing oversight, regulatory support, QC release testing, and stability programs. Our team can function as an extension of a sponsor's internal development and quality organization, helping coordinate technical activities across multiple external partners. CA Analytical is also building an internal drug product portfolio that includes small-molecule and liposomal formulations. We are particularly interested in partnering with organizations developing novel or alternative drug-delivery technologies that can be combined with existing or emerging therapeutics to improve delivery, durability, usability, and ultimately advance medicines toward clinical application.
Industries
N/A
Nr. of Employees
small (1-50)
CA Analytical Testing Services
50 Lakeview Pkwy Ste 112, Vernon Hills, IL 60061
Services
Comprehensive material release, process chemical, and product testing to ensure regulatory compliance and batch consistency for pharmaceutical, biotechnology, and medical device industries.
Analytical support for product lifecycle, including method development, impurity characterization, and validation throughout pharmaceutical and biotechnological development phases.
Limulus Amebocyte Lysate (LAL), bioburden, microbial enumeration, specified microorganism, and sterility testing supporting pharmaceutical and medical device quality requirements.
Formulation design, lab and pilot scale batch preparation, stability assessments, compatibility studies, process scale-up, and microsphere/encapsulation development.
Testing of pharmaceuticals, medical devices, and packaging for migratory compounds using advanced analytical workflows with full compliance documentation.
Pyrolysis-GC/MS testing platform for detection, identification, and mass-based quantitation of microplastics and nanoplastics in diverse sample matrices.
Comprehensive material release, process chemical, and product testing to ensure regulatory compliance and batch consistency for pharmaceutical, biotechnology, and medical device industries.
Analytical support for product lifecycle, including method development, impurity characterization, and validation throughout pharmaceutical and biotechnological development phases.
Limulus Amebocyte Lysate (LAL), bioburden, microbial enumeration, specified microorganism, and sterility testing supporting pharmaceutical and medical device quality requirements.
Formulation design, lab and pilot scale batch preparation, stability assessments, compatibility studies, process scale-up, and microsphere/encapsulation development.
Testing of pharmaceuticals, medical devices, and packaging for migratory compounds using advanced analytical workflows with full compliance documentation.
Pyrolysis-GC/MS testing platform for detection, identification, and mass-based quantitation of microplastics and nanoplastics in diverse sample matrices.
Expertise Areas
- Analytical method development
- Quality control testing
- Regulatory
- GMP analytical services
Key Technologies
- High-performance liquid chromatography (HPLC)
- Ultra-high performance liquid chromatography (UHPLC)
- Gas chromatography–mass spectrometry (GC-MS)
- Liquid chromatography–mass spectrometry (LC-MS/MS)
Key People
News & Updates
An article on the importance and methodology of microplastics analysis across environmental, product development, and public health research.
Discusses extractables and leachables testing approaches and regulatory alignment for pharmaceuticals, devices, and combination products.
Details use of advanced chromatography systems in regulated pharmaceutical and device testing applications.
Explains compendial water testing approaches for pharmaceutical and biotechnological applications.
Participation at the upcoming BioMaP General Member Meeting, aligning with national biodefense readiness and development of critical medical countermeasures.
An article on the importance and methodology of microplastics analysis across environmental, product development, and public health research.
Discusses extractables and leachables testing approaches and regulatory alignment for pharmaceuticals, devices, and combination products.
Details use of advanced chromatography systems in regulated pharmaceutical and device testing applications.
Explains compendial water testing approaches for pharmaceutical and biotechnological applications.
Participation at the upcoming BioMaP General Member Meeting, aligning with national biodefense readiness and development of critical medical countermeasures.